The Treatment-induced Neuropathy Assessment Scale (TNAS): a psychometric update following qualitative enrichment by Tito R. Mendoza, Loretta A. Williams, Qiuling Shi, Xin Shelley Wang, Oluwatosin Bamidele, Jeanie F. Woodruff, Charles S. Cleeland

Connect to this object online.

Evaluation of the psychometric properties and minimally important difference of the MD Anderson Symptom Inventory for malignant pleural mesothelioma (MDASI-MPM) by Tito R. Mendoza, Loretta A. Williams, Karen N. Keating, Jonathan Siegel, Cem Elbi, Anna K. Nowak, Raffit Hassan, Brian Cuffel, Charles S. Cleeland

Connect to this object online.

Application of a Bayesian graded response model to characterize areas of disagreement between clinician and patient grading of symptomatic adverse events by Thomas M. Atkinson, Bryce B. Reeve, Amylou C. Dueck, Antonia V. Bennett, Tito R. Mendoza, Lauren J. Rogak, Ethan Basch, Yuelin Li

Connect to this object online.

Measuring symptom burden in patients with cancer during a pandemic: the MD Anderson symptom inventory for COVID-19 (MDASI-COVID) by Loretta A. Williams, Meagan S. Whisenant, Tito R. Mendoza, Angela E. Peek, Donna Malveaux, Donna K. Griffin, Darcy A. Ponce, Bruno Palma Granwehr, Ajay Sheshadri, Katherine A. Hutcheson, Sara M. Ali, Susan K. Peterson, John V. Heymach, Charles S. Cleeland, Ishwaria M. Subbiah

Connect to this object online.